Dextrose (dextrose monohydrate) NDC 65219-236

Product information

Brand name (proprietary)

Dextrose

Generic name (nonproprietary)

dextrose monohydrate

Active ingredients

Dextrose monohydrate — 5000 mg/100mL

Dosage form

Injection, Solution

Route

Intravenous

Labeler

Fresenius Kabi USA, LLC

Product type

Prescription drug

Marketing category

ANDA — Abbreviated New Drug Application (generic)Application ANDA 207449

Marketing start

Oct 21, 2016

Listing expires

Dec 31, 2026

Identifiers

Product ID 65219-236_39549d47-5040-4b1f-8b46-f0dd95832e1eSPL ID 39549d47-5040-4b1f-8b46-f0dd95832e1eSPL set ID bd250a46-d229-4e80-b5a1-b34169ccecc4RxCUI 1795607, 1795609, 1795610, 1795616UNII LX22YL083G

Billing references

What Med-Code can say about coding this product, and where each statement comes from. Nothing here is inferred from the name alone.

HCPCS codeNo match

No drug-specific HCPCS code in Med-Code's directory for this product. The directory is curated and not complete — check the current CMS HCPCS file before billing.

Administration

Drug administration (CPT 96360–96549)

When a clinician administers the drug, the administration is reported separately. Codes in this range cover hydration, therapeutic injections and infusions, and chemotherapy or other complex drug administration. The right code depends on route, duration and drug type, and self-administered drugs are not billed this way.

How CPT relates to drug billing

NDC on a medical claim

N465219023610 followed by a unit qualifier and the quantity Copy

Package 65219-0236-10. Unit qualifiers: F2 (international unit), GR (gram), ME (milligram), ML (milliliter), UN (unit (each)). The qualifier and quantity depend on what was given. About the N4 qualifier

Product label

Label details couldn’t be retrieved right now. Open the label on DailyMed.

Other NDCs under ANDA 207449

Products listed under the same FDA application: other strengths and forms, and repackagers who relabel the same product.